Salute e Benessere

Life-saving inventor Shelley Savage wins two Business Worldwide Magazine Global…

Every day, over 1,000 people die of SCA in the United States alone, and all over the world it remains one of the leading causes of sudden death. Doctors want more Automated External Defibrillators (AEDs) to be available everywhere, but even though more are being installed in public spaces survival rates are still alarmingly low. Just 1% of people who experience Sudden Cardiac Arrest in public survive, partly due to low availability of equipment but also because of lack of training and/or…

Essity once again recognized as a diversity leader by Financial Times

"With a diverse and inclusive culture, we achieve stronger engagement and better decision-making. I'm pleased to see that Financial Times has once again recognized Essity in this important area," says Magnus Groth, President and CEO at Essity. "With a diverse and inclusive culture, we achieve stronger engagement and better decision-making. I'm pleased to see that Financial Times has once again recognized Essity in this important area," saysMagnus Groth, President and CEO at…

InSilicoTrials Awarded 2023 Innovation Radar Prize Established by European…

The Innovation Radar Prize, initiated by the European Commission in 2015, celebrates innovators who have received EU funding and are working to transition their innovations from the laboratory to the market. This year's Innovation Radar Summit, held in Lisbon in partnership with Eura AG, Dealroom.co, the European Startup Nations Alliance (ESNA), Startup Lisboa, and Microsoft, showcased the most promising innovations that have the potential to transform industries and improve the quality of life…

Orion Corporation: Managers' transactions – Mikael Silvennoinen

ORION CORPORATIONMANAGERS' TRANSACTIONS16 NOVEMBER 2023 at 10.15 EET Orion Corporation: Managers' transactions – Mikael Silvennoinen Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons.Orion Oyj - Managers' Transactions ____________________________________________ Person subject to the...

Orion Corporation: Managers' transactions – Agendum Oy

ORION CORPORATIONMANAGERS' TRANSACTIONS16 NOVEMBER 2023 at 10.15 EET Orion Corporation: Managers' transactions – Agendum Oy Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons.Orion Oyj - Managers' Transactions ____________________________________________ Person subject to the notification...

TARAMAR - The Evolution of an Anti-Aging Serum into a Healing Skin Constructor…

The visionary trailblazer behind this transformation, Professor Gudrun Marteinsdóttir, founder of TARAMAR, experienced a profound shift from her former role as a professor of fishery sciences at the University of Iceland to becoming an entrepreneur focusing on formulating toxic free marine-based skincare. Her motivation stemmed from the desire to restore her skin's youthful vitality and radiance as she reached the age of 50, where her complexion had succumbed to a lacklustre, pallid, and dry…

HFMA gives 5 reasons to take your daily supplements

Dr Michele Sadler, scientific advisor to the HFMA, comments, "Intakes from the habitual diet of many people in the UK doesn't always meet dietary requirements. While everyone should aim to eat a heathy balanced diet, taking a daily supplement can be helpful to make up any shortfall in micronutrient intake." DrMichele Sadler, scientific advisor to the HFMA, comments, "Intakes from the habitual diet of many people in the UK doesn't always meet dietary requirements. While everyone…

ZINZINO AB (PUBL): INTERIM REPORT THIRD QUARTER 2023

The total revenues during the third quarter of 2023 amounted to SEK 436.9 (349.9) million, which corresponded to 25% (12%) growth compared to the corresponding quarter of the previous year. The EBITDA result increased to SEK 71.2 (25.4) million for the quarter and the EBITDA margin increased to 16.3% (7.3%). As before, behind the margin improvement are primarily changes in the sales mix, efficiencies and economies of scale. During the quarter, a very successful sales launch was carried out in…

Implantica's RefluxStop™ health economic research, showing superior…

ISPOR is globally recognized as the leading scientific and educational organization for health economics and outcomes research (HEOR) and its use in the healthcare decision-making process. It's an ideal venue to share new data with the global health economics and scientific community, including Health Technology Assessment (HTA), Payers, and reimbursement experts and influencers. ISPOR is globally recognized as the leading scientific and educational organization for health economics and...

SciBase and Skin and Cancer Institute partner to advance AI-driven skin cancer…

"We are very pleased to announce our collaboration with the Skin and Cancer Institute. In addition to the early detection benefits for patients, the partnership means clinicians at several of their California offices will have access to state-of-the-art melanoma detection technology at point-of-care. For SciBase, this means we expand and establish a coast-to-coast reach that provides patients with access to early melanoma detection technology. It also helps introduce Nevisense to more US…

Bavarian Nordic Announces Interim Results for the First Nine Months of 2023

COPENHAGEN, Denmark, November 16, 2023– Bavarian Nordic A/S (OMX: BAVA) announced today its interim financial results for the first nine months of 2023 and business progress for the third quarter of 2023. Revenue for the first nine months increased by 148% to DKK 4,615 million compared to the same period last year, while the operating profit (EBITDA) increased to DKK 1,552 million.The increased revenue was driven by growth across both business areas: travel health and public...

Apollo Hospitals Celebrates 25 Years of India's First Liver Transplant Program

Dr. Anupam Sibal, Group Medical Director & Senior Pediatric Gastroenterologist, said, "In the last 25 years, the liver transplant program at Apollo Institutes has achieved remarkable milestone giving hope to patients with end-stage liver diseases. Sanjay Kandasamy, India's first liver transplant recipient is now a successful doctor, a beacon of hope for those with no hope. Success stories of our patients have encouraged us to create the most advanced transplant ecosystem, performing…

ONWARD® Reports Q3 Business Update and Year-To-Date Highlights

Completing activities required for ARC-EX® FDA submission Expanded HemON Study as precursor to ARC-IM® Empower BP pivotal study First-in-human use of ARC-IM BCI for upper limbs Potential for ARC Therapy ™to improve mobility after Parkinson's disease published in Nature Medicine ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, function, and independence...

Roche launches automated serology hepatitis E virus tests, including a test to…

It is estimated that one third of the global population could be at risk for infection with Hepatitis E virus.1The new tests allow clinicians to diagnose acute and chronic infections amongst patients presenting with or without signs of the illness as recommended by the European Association for the Study of the Liver (EASL).2The tests complete Roche's panel used for the differential diagnosis of acute viral hepatitis caused by the hepatitis A, B, C and E viruses.Basel, 16...

IBA Business Update – Third Quarter 2023

Louvain-La-Neuve, Belgium, 16 November 2023- IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology, today announces its business update for the third quarter ending 30 September 2023. Group Overview Strong backlog conversion acceleration in the third quarter across all businesses with good momentum to continue into the fourth quarter, reconfirming cyclical nature of business with revenue recognition heavily H2 weightedGood equipment order...

IV Catheters Market to Reach $17.8 Billion, Globally, by 2032 at 7.5% CAGR…

Request Sample of the Report on IV Catheters Market Forecast 2032- https://www.alliedmarketresearch.com/request-sample/14789 Request Sample of the Report on IV Catheters Market Forecast 2032-https://www.alliedmarketresearch.com/request-sample/14789 Prime determinants of growth Rise in prevalence of chronic diseases, surge in number of surgical procedures, and technological advancements in intravenous equipment drive the growth of the global IV catheters market. However, risk...

Flow Cytometry Market to Reach $16.6 Billion by 2032 at 10.3% CAGR: Allied…

Request Sample of the Report on Flow Cytometry Market Forecast 2032- https://www.alliedmarketresearch.com/request-sample/90 Request Sample of the Report on Flow Cytometry Market Forecast 2032-https://www.alliedmarketresearch.com/request-sample/90 Prime determinants of growth The flow cytometry market has experienced significant growth due to technological advancements, high adoption of flow cytometry techniques in disease diagnosis, and surge in adoption of flow cytometry...

A BLAST OF COLOUR: ARMIN STROM INTRODUCES THE TRIBUTE 1 WITH FUMÉ DIALS AND…

A statement of simplicity, the Armin Strom way. The Tribute 1 is the independent manufacturer's unique take on the most fundamental of timekeepers, the three-hand watch. Perhaps the most essential expression of the art of watchmaking, every detail in the Tribute 1 is rendered meticulously to achieve a harmonious, integral and highly original piece like no other. Now, it takes on a more dramatic look with fumé dials in four striking hues, with guilloché dial plates by celebrated independent…

Jiahui Health develops international CAR-T treatment platform in China

Jiahui International Cancer Center has established an international CAR-T treatment team and has successfully carried out treatments in collaboration with various companies, including IASO Biotechnology and Fosun Kite. Jiahui's CAR-T multidisciplinary treatment team, led by Dr. Vicky LEE, Director of the Jiahui International Cancer Center and Chief of Medical Oncology at Jiahui International Cancer Center, has conducted a series of studies in the clinical practice of novel technologies and has…

Amorepacific receives the CES Innovation Award for fifth consecutive year

Awarded in the CES 2024 Digital Health category, the 'Lipcure Beam' is a groundbreaking beauty tech device that combines lip diagnosis, care, and makeup capabilities in one unit. Awarded in the CES 2024 Digital Health category, the 'Lipcure Beam' is a groundbreaking beauty tech device that combines lip diagnosis, care, and makeup capabilities in one unit. The 'Lipcure Beam' cap houses a precision sensor capable of diagnosing the condition of the lips. It instantly detects moisture levels and...

Type 1 Diabetes Market to Accelerate Substantially During the Study Period…

Key Takeaways from the Type 1 Diabetes Market Report Key Takeaways from the Type 1 Diabetes Market Report Discover which therapies are expected to grab the major type 1 diabetes market share @Type 1 Diabetes Market Report Type 1 Diabetes Overview Diabetes is medically categorized into three primary types, with Type 1 diabetes, Type 2 diabetes, and gestational diabetes being the main classifications. Type 1 diabetes, often abbreviated as T1D, results from an autoimmune...

Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC

Regulated InformationLeuven, BELGIUM, Boston, MA, US – November 15, 2023 – 7.00 PM CETOxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company developing next generation standard of care ophthalmic therapies, with clinical stage assets in vascular retinal disorders, today announced that, pursuant to Belgian Transparency legislation 1it has received a transparency notification as follows: Oxurion received a transparency notification on November 14, 2023, from Atlas Special...

Christian Praxmarer becomes new CEO of Single Use Support

Former Managing Director and COO Christian Praxmarer will become the new CEO of Single Use Support on November 15, 2023. Together with co-founder Johannes Kirchmair, he will now form the top management of the successful Tyrolean company. The successful recipe for management with two CEOs will now be continued with co-founder Johannes Kirchmair and Christian Praxmarer. Kirchmair knows that the company is in good hands: "The choice was very easy. Christian Praxmarer will work with the…

Veterinary Equipment and Supplies Market Worth $3.2 Billion | MarketsandMarkets

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=14169630 Download an Illustrative overview:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=14169630 Browse in-depth TOC on "Veterinary Equipment and Supplies Market" 250 - Tables 150 - Figures 350 - Pages Veterinary Equipment and Supplies Market Scope: Basic equipment in technology segment accounted for the largest share of the global veterinary equipment and...

Altri Comunicati